| Q38028610 | Acute treatment of migraines |
| Q34647540 | Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache |
| Q40443480 | Dexamethasone prevents relapse after emergency department treatment of acute migraine: a randomized clinical trial |
| Q24651176 | Diagnosis and management of the primary headache disorders in the emergency department setting |
| Q38101880 | Dihydroergotamine: a review of formulation approaches for the acute treatment of migraine |
| Q38363902 | Inpatient management of migraine |
| Q39284203 | Intravenous sodium valproate aborts migraine headaches rapidly |
| Q36405681 | Intravenous treatment of chronic daily headaches in the outpatient headache clinic |
| Q38946597 | Is the Generally Held View That Intravenous Dihydroergotamine Is Effective in Migraine Based on Wrong "General Consensus" of One Trial? A Critical Review of the Trial and Subsequent Quotations |
| Q34321461 | Ketorolac in the treatment of acute migraine: a systematic review |
| Q39235777 | Ketorolac versus meperidine and hydroxyzine in the treatment of acute migraine headache: a randomized, prospective, double-blind trial |
| Q39459778 | Ketorolac. A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management |
| Q38769719 | Metoclopramide for Acute Migraine Treatment in the Emergency Department: An Effective Alternative to Opioids |
| Q51458583 | Nitrous oxide for the treatment of acute migraine headache. |
| Q37705594 | Parenteral metoclopramide for acute migraine: meta-analysis of randomised controlled trials |
| Q36748706 | Preventive agents for migraine: focus on the antiepileptic drugs |
| Q40698410 | Recent advances in the acute management of migraine and cluster headaches |
| Q34243951 | Rescue therapy for acute migraine, part 1: triptans, dihydroergotamine, and magnesium |
| Q37981719 | Rescue therapy for acute migraine, part 2: neuroleptics, antihistamines, and others |
| Q37992176 | Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications |
| Q82704934 | Symptomatic treatment of migraine: when to use NSAIDs, triptans, or opiates |
| Q46572332 | Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors |
| Q34187950 | The clinician's approach to the management of headache. |
| Q37340160 | The pharmacological management of migraine, part 1: overview and abortive therapy |
| Q41677343 | The pharmacology of medications used in treating headache |
| Q40852736 | Therapeutic advances in migraine |
| Q39459850 | Transnasal butorphanol in the emergency department management of migraine headache |
| Q36557463 | Treatment of headache in the elderly |
| Q38680371 | Update of Inpatient Treatment for Refractory Chronic Daily Headache |
| Q82105544 | Use of dopamine antagonists in treatment of migraine |